Palle Christophersen
Gründer bei SANA AB
Vermögen: 145 021 $ am 30.04.2024
Aktive Positionen von Palle Christophersen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANA AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | - |
Gründer | 01.01.2011 | - | |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Palle Christophersen
Ehemalige bekannte Positionen von Palle Christophersen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 28.05.2010 | 01.01.2012 |
Ausbildung von Palle Christophersen
University of Copenhagen | Doctorate Degree |
Statistik
International
Dänemark | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Founder | 1 |
Sektoral
Transportation | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
SANA AB | Health Technology |
Private Unternehmen | 1 |
---|---|
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
- Börse
- Insiders
- Palle Christophersen
- Erfahrung